{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/molluscum-contagiosum/management/management-of-molluscum-contagiosum/","result":{"pageContext":{"chapter":{"id":"dcb1740a-7b4f-5130-88e2-0c261d04f2cf","slug":"management-of-molluscum-contagiosum","fullItemName":"Scenario: Management of molluscum contagiosum","depth":2,"htmlHeader":"<!-- begin field 4734222a-0178-4e27-8290-eedfdbd83622 --><h2>Scenario: Management of molluscum contagiosum</h2><!-- end field 4734222a-0178-4e27-8290-eedfdbd83622 -->","summary":"Covers the management of people with molluscum contagiosum.","htmlStringContent":"<!-- begin item cf132fc1-5991-49f3-8410-bad7a8e8e0e4 --><!-- begin field 50fa59a1-83b6-48c9-acd1-acbc0159ac96 --><p>From age 1 month onwards.</p><!-- end field 50fa59a1-83b6-48c9-acd1-acbc0159ac96 --><!-- end item cf132fc1-5991-49f3-8410-bad7a8e8e0e4 -->","topic":{"id":"ca6a0ee0-b108-5948-a385-2ca9fd25f3f2","topicId":"0b781cca-ea92-4b7b-8198-202123cf1f41","topicName":"Molluscum contagiosum","slug":"molluscum-contagiosum","lastRevised":"Last revised in March 2017","chapters":[{"id":"dd0236c1-7131-5ffc-9544-c838a578bb7f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c1b8ce66-a218-51e1-aeb2-df50d8bc8235","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ad5fa2a4-8f1f-515a-bdfe-ad5d3c1218d0","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"628980d1-e848-5813-bf5d-7d8c5ded9093","slug":"changes","fullItemName":"Changes"},{"id":"c5c3bba0-b1f8-567a-b3da-bd2020fc62d0","slug":"update","fullItemName":"Update"}]},{"id":"fbface41-a9ba-543f-8448-2a1ac5fcda23","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ba12888d-a27b-570d-9c3e-d444c24e98ca","slug":"goals","fullItemName":"Goals"},{"id":"c381e772-090b-54ad-8c8b-948a10596813","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"abc6b2ad-8415-5d64-bf0f-581d003f886c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6d3b1c5b-a093-5bc3-87db-2e1aec362c2d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4cdc5c27-8f2d-53ee-8963-7a3e75a3d0b0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"58267d0d-6973-5285-837b-f88dfa2e6f8b","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d3650fae-607a-55d8-81fb-ae35a0dcc308","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"191da30b-bcd4-55d5-b89c-d352f7ce1c77","slug":"definition","fullItemName":"Definition"},{"id":"2b67e01c-dd73-573f-b2fd-6f42ba41e83c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"98ee9983-01e7-57c1-a127-1314d769aecd","slug":"complications","fullItemName":"Complications"},{"id":"4c0160a6-5fee-573e-82ea-e0fe234f0693","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"aa13c7cd-5163-5ecd-a0d0-d33098b5ff8f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1a19466f-a9a4-5044-8fcd-58f163f7b617","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c0bedc69-d724-5508-b81a-e79b93b299c1","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3f0b90f1-bd2b-5a56-b6fa-2c394943056c","fullItemName":"Management","slug":"management","subChapters":[{"id":"dcb1740a-7b4f-5130-88e2-0c261d04f2cf","slug":"management-of-molluscum-contagiosum","fullItemName":"Scenario: Management of molluscum contagiosum"}]},{"id":"48af62b0-7074-5c67-96ef-a77089c2fff5","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"b1d95fcd-7d8c-5cdd-b066-5681fd7eb1b5","slug":"treatments-for-molluscum-contagiosum","fullItemName":"Treatments for molluscum contagiosum"}]},{"id":"16dde61e-edd3-5810-850c-a694c5cf24ba","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"49817209-cee0-5e63-8d8c-2ad0557e8fa5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"347f7fe5-5fbe-589b-be8c-c954c9227744","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"34f2a8ae-e88a-5199-af60-a42fe2a890f8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d682e79f-8169-56aa-a39f-be977cc17d27","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7c33c5bd-f499-5cef-92c6-084759dce0ad","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"79d11630-76b7-5fd5-a4ae-d5149831f426","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3f0b90f1-bd2b-5a56-b6fa-2c394943056c","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"3a0fb526-38c1-5f7c-9fe0-3cdd0c1428f6","slug":"self-care-advice","fullItemName":"Self-care advice","depth":3,"htmlHeader":"<!-- begin field e309d22f-f892-41e2-954e-51675dc3fac3 --><h3>What self-care advice should I give someone with molluscum contagiosum?</h3><!-- end field e309d22f-f892-41e2-954e-51675dc3fac3 -->","summary":null,"htmlStringContent":"<!-- begin item 0f4d8cdf-f443-40be-b069-a1e50c03fdd0 --><!-- begin field 0a3a33a9-41d2-4f44-a724-599a61f7e55e --><ul><li>Molluscum does not require treatment in immunocompetent people, unless symptoms or complications occur [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BMJ, 2017</a>].</li><li>Reassure people that molluscum contagiosum is a self-limiting condition.</li><li>Spontaneous resolution usually occurs within 18 months.</li><li>People should be advised against squeezing mollusca to avoid spread of the infectious material as well as reducing the risk of super-infections.</li><li>Explain that lesions are contagious and it is sensible to avoid sharing towels, clothing, and baths with uninfected people, such as siblings.</li><li>Encourage people not to scratch the lesions. If this is problematic, consider treatment to alleviate the itch.</li><li>Exclusion from school, gym, or swimming is not necessary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">PHE, 2016</a>].</li></ul><!-- end field 0a3a33a9-41d2-4f44-a724-599a61f7e55e --><!-- end item 0f4d8cdf-f443-40be-b069-a1e50c03fdd0 -->","subChapters":[{"id":"534126c2-55ba-5815-a3bf-07d30a328f73","slug":"basis-for-recommendation-166","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ad22164f-d603-4401-82cc-191ea19fb3cd --><h4>Basis for recommendation</h4><!-- end field ad22164f-d603-4401-82cc-191ea19fb3cd -->","summary":null,"htmlStringContent":"<!-- begin item 16684d88-8ef0-496b-8b25-431b592e1bec --><!-- begin field f5911339-065d-45fc-9453-57b3cd7fea2b --><p>These recommendations are based on expert opinion from a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>] and [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BMJ, 2017</a>] and guidelines from Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">PHE, 2016</a>].</p><ul><li>The mean duration of each lesion is 13 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Olsen, 2015</a>].</li><li>There is no trial evidence to support the recommendations to limit the spread of infection.</li></ul><!-- end field f5911339-065d-45fc-9453-57b3cd7fea2b --><!-- end item 16684d88-8ef0-496b-8b25-431b592e1bec -->","subChapters":[]}]},{"id":"00a339d1-9b3c-5bf1-9d6d-4a29f09769a0","slug":"treating-molluscum-contagiosum","fullItemName":"Treating molluscum contagiosum","depth":3,"htmlHeader":"<!-- begin field 9ebd1bc7-bcc3-47ae-b373-4cb05dca20f1 --><h3>How should I treat molluscum contagiosum?</h3><!-- end field 9ebd1bc7-bcc3-47ae-b373-4cb05dca20f1 -->","summary":null,"htmlStringContent":"<!-- begin item 6ba73adb-1896-48e3-9c38-7faf3d0c53de --><!-- begin field f55418f4-e9c5-46fc-bf29-027dc9968821 --><ul><li>Treatment is not usually recommended in primary care.</li><li>If lesions continue to be troublesome, extensive or there is diagnostic uncertainty, a person should be referred for specialist advice and treatment. </li><li>Eczema or inflammation can develop around lesions prior to resolution. Treatment may be required if:<ul><li>Itching is problematic; prescribe an emollient and a mild topical corticosteroid (such as hydrocortisone 1%).</li><li>The skin looks infected (e.g. oedema, crusting); prescribe a topical antibiotic (such as fusidic acid 2%).</li><li>For more information see the sections on the treatment of flares (<a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/management/mild-eczema/\">mild</a>, <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/management/moderate-eczema/\">moderate</a> or <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/management/severe-eczema/\">severe</a>) and <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/management/infected-eczema/#management\">treatment of infected eczema</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a>.</li></ul></li></ul><!-- end field f55418f4-e9c5-46fc-bf29-027dc9968821 --><!-- end item 6ba73adb-1896-48e3-9c38-7faf3d0c53de -->","subChapters":[{"id":"2c0c07c6-f1a5-5aaf-8a91-d0de808ae23f","slug":"basis-for-recommendation-f90","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field eec25640-e77d-4bc5-a3cd-5196b75cfebc --><h4>Basis for recommendation</h4><!-- end field eec25640-e77d-4bc5-a3cd-5196b75cfebc -->","summary":null,"htmlStringContent":"<!-- begin item f905856f-c46d-4ca0-81c4-d52db60923d8 --><!-- begin field c1644472-9ad2-4bf4-81a9-0e02830f8fe3 --><p>These recommendations are based on good clinical practice and expert opinion from review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BMJ, 2017</a>]:</p><ul><li>Most people do not require treatment, as lesions will usually resolve within 1–2 years, and do not limit activities or cause symptoms.</li><li>Treatment may result in pain, hyperpigmentation, hypopigmentation or scarring and therefore should only be initiated after careful consideration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>].</li><li>CKS did not identify any randomized controlled trials comparing active treatment with watchful waiting.</li><li>An American study [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Basdag, 2015</a>] demonstrated no shortening of symptoms if molluscum is treated, even in children with atopic dermatitis. </li><li>A Cochrane review concluded there was insufficient evidence to determine whether treatments are effective [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">van der Wouden et al, 2009</a>]. In addition, there is no evidence that treatment prevents spread of infection, and the approaches used can be painful and lead to scarring.</li><li>Eczematous reactions are a common complication, especially in children with atopy and should be treated promptly [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BMJ, 2017</a>]. </li></ul><!-- end field c1644472-9ad2-4bf4-81a9-0e02830f8fe3 --><!-- end item f905856f-c46d-4ca0-81c4-d52db60923d8 -->","subChapters":[]}]},{"id":"b6aad5d9-ea9a-5971-862f-a638942d6597","slug":"treating-anogenital-molluscum-contagiosum","fullItemName":"Treating anogenital molluscum contagiosum","depth":3,"htmlHeader":"<!-- begin field 35357f58-38f7-4efe-9356-15555f1dc0c1 --><h3>How should I treat anogenital molluscum contagiosum?</h3><!-- end field 35357f58-38f7-4efe-9356-15555f1dc0c1 -->","summary":null,"htmlStringContent":"<!-- begin item b188b14f-7dcb-45cd-8aa9-e5363895c91a --><!-- begin field 5a5ed2eb-9954-4d1b-975f-377ceba94cef --><ul><li>No treatment may be necessary as lesions often spontaneously regress.</li><li>The person should be advised the following: <ul><li>To use condoms, although this may only offer partial protection as transmission may still occur by skin-to-skin contact.</li><li>Molluscum is not a sexually transmitted infection and does not require contact tracing, unless other STIs co-exist.</li><li>Referral or self-referral to genito-urinary medicine for screening for other sexually transmitted infections.</li></ul></li><li>Podophyllotoxin 0.5% is often used to treat anogenital warts and has been demonstrated to be an effective treatment for molluscum contagiosum.<ul><li>The medication is applied by the patient twice a day for 3 consecutive days and can be repeated after a week if necessary.</li></ul></li><li>Imiquimod 5% cream has some evidence for its use for anogenital molluscum contagiosum, although it is unlicensed. <ul><li>It is applied to the lesions 3 times a week and washed off 6-10 hours later. </li></ul></li><li>Cryotherapy has limited evidence for anogenital molluscum but has been used regularly in GUM clinics.</li><li>The following treatments have little evidence base, are considered too harsh or impractical for genital skin and should therefore be avoided: curettage, pulsed dye lasers, salycilic acid, trichloracetic acid, benzoyl peroxide and retinoids. </li></ul><!-- end field 5a5ed2eb-9954-4d1b-975f-377ceba94cef --><!-- end item b188b14f-7dcb-45cd-8aa9-e5363895c91a -->","subChapters":[{"id":"5da0f5ee-ebfb-580a-b38f-f10012af6b5a","slug":"basis-for-recommendation-ca3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a7f9b67f-b382-4938-8433-e36a71d0e952 --><h4>Basis for recommendation</h4><!-- end field a7f9b67f-b382-4938-8433-e36a71d0e952 -->","summary":null,"htmlStringContent":"<!-- begin item ca3e4b6c-0d72-48fe-a082-a09ea781d6f9 --><!-- begin field 43c58f31-6ed6-433b-9129-41f16f704899 --><p>This recommendation is based on <em>UK national guideline for the management of genital molluscum in adults</em> (2014) written by the Clinical Effectiveness Group, British Association for Sexual Health and HIV [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BASHH, 2014</a>] and the Royal College of General Practitioners [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">RCGP, 2013</a>].</p><h5>Further information</h5><p>The treatment options for anogenital molluscum contagiosum are similar to those for non-genital molluscum contagiosum. There is limited evidence that treatments commonly used for the treatment of genital warts (podophyllotoxin and imiquimod) are also effective for genital molluscum contagiosum. Most studies have been carried out in secondary care, and would normally be offered in a genito-urinary medicine clinic in the UK.</p><ul><li>Podophyllotoxin<strong>: </strong>a randomized controlled trial (RCT) (n=120) of people with mainly genital molluscum contagiosum compared treatment with podophyllotoxin 0.5% cream, podophyllotoxin 0.3% cream and placebo. Participants self-administered the cream twice daily for 3 consecutive days per week, for up to 4 weeks. Cure was defined as total clearance of the lesions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Syed et al, 1994</a>]:<ul><li>After 1 month, cure was achieved in 92% of the podophyllotoxin 0.5% group, in 52% of the podophyllotoxin 0.3% group, and in 16% of the placebo group.<!--?0.001).          --><!--?0.001).          --></li></ul></li><li>Imiquimod: a double-blind RCT (n=100) of people with thigh or genital molluscum contagiosum compared imiquimod cream 1% with placebo cream. Participants self-administered the cream three times a day for 5 consecutive days per week. Cure was defined as total clearance of the lesions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Syed et al, 1998</a>]:<ul><li>After 4 weeks of treatment, 82% of the imiquimod group were cured compared with 16% of the placebo group.<!--?0.0001). 49=\"\" among=\"\"          --><!--?0.0001).          --><p><!--?0.0001). 49=\"\" among=\"\"          --><!--?0.0001).          --></p></li></ul></li></ul><!-- end field 43c58f31-6ed6-433b-9129-41f16f704899 --><!-- end item ca3e4b6c-0d72-48fe-a082-a09ea781d6f9 -->","subChapters":[]}]},{"id":"f52e4b06-6c1f-5412-9900-9bc034182bbb","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 61069c78-a2f2-4cbe-816e-1d1b18c628b9 --><h3>When should I refer a person with molluscum contagiosum?</h3><!-- end field 61069c78-a2f2-4cbe-816e-1d1b18c628b9 -->","summary":null,"htmlStringContent":"<!-- begin item 3f55a311-06d4-4d62-ae4e-42b5b56a0c1c --><!-- begin field 8db0ba78-cbc9-47cc-aa9f-c95eb9132f3c --><ul><li>For people who are HIV-positive with extensive lesions, refer urgently to a HIV specialist.</li><li>People with mild eyelid lesions may be managed by an Optometrist. However, for people with eyelid-margin or ocular lesions <em>and </em>associated red eye, refer urgently to an Ophthalmologist.</li><li>Refer adults with anogenital lesions to genito-urinary medicine, for screening for other sexually transmitted infections. In children, lesions are commonly seen in anogenital areas, but referral for suspected sexual abuse should only be arranged if there is other evidence to suggest this.</li><li>Consider referring to a Dermatologist if:<ul><li>There is diagnostic uncertainty.</li><li>The person is known to be immunocompromised.</li><li>Lesions are extensive and painful (although inflamed lesions may indicate resolution).</li></ul></li><li>The following treatments may be considered by a specialist [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>]:<ul><li>Physical (e.g. cryotherapy, curettage, cautery, pulsed dye laser, phototherapy, electron beam therapy).</li><li>Chemical destructive (e.g. Trichloroacetic acid).</li><li>Chemical non-destructive (e.g. cantharidin, potassium hydroxide 10%, benzoyl peroxide 10%, and retinoids).</li><li>Immune modulating agents (podophyllin, and imiquimod 5%).</li><li>Antiviral agents (e.g. Cidofovir).</li></ul></li></ul><!-- end field 8db0ba78-cbc9-47cc-aa9f-c95eb9132f3c --><!-- end item 3f55a311-06d4-4d62-ae4e-42b5b56a0c1c -->","subChapters":[{"id":"93ab3664-c74f-5a7d-8187-4a9c22646031","slug":"basis-for-recommendation-ae9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d1498827-3b17-44cf-b756-4655ddaef2f2 --><h4>Basis for recommendation</h4><!-- end field d1498827-3b17-44cf-b756-4655ddaef2f2 -->","summary":null,"htmlStringContent":"<!-- begin item ae9feecd-f008-4dd8-915f-8f135f492477 --><!-- begin field da1d9f82-5d57-47a0-b892-f94f5f305485 --><p>These recommendations are based on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BASHH, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">BMJ, 2017</a>] and what CKS considers to be good clinical practice in the UK.</p><ul><li>A specialist may offer diagnostic investigations (e.g. skin biopsy) and provide treatments not available in primary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Primary Care Dermatology Society, 2016</a>].  </li><li>The evidence for curettage, phenol ablation, imiquimod, potassium hydroxide 10%, podophyllin, and cantharidin treatments is limited to small uncontrolled trials [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>].</li><li>Rarely, eyelid or ocular molluscum contagiosum can cause keratoconjunctivitis, follicular conjunctivitis or pannus which need urgent referral to Ophthalmology. Other mild eyelid complications may be managed by an Optometrist [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">The College of Optometrists, 2014</a>].</li><li>Molluscum contagiosum in people with immunosuppression can be progressive and resistant to treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/molluscum-contagiosum/references/\">Chen, 2013</a>].</li></ul><!-- end field da1d9f82-5d57-47a0-b892-f94f5f305485 --><!-- end item ae9feecd-f008-4dd8-915f-8f135f492477 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}